Stay updated on INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial

Sign up to get notified when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    15 days ago
    Change Detected
    Summary
    Minor UI text and label changes were made, including the addition of glossary toggle options and small wording/case updates (e.g., 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-23T10:16:28.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed; this update does not change the study content, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T05:56:34.000Z thumbnail image
  4. Check
    51 days ago
    Change Detected
    Summary
    Footer now includes Revision: v3.3.3; the HHS Vulnerability Disclosure and Revision: v3.3.2 items were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-17T18:56:09.000Z thumbnail image
  5. Check
    73 days ago
    Change Detected
    Summary
    Publications description updated to 'These publications are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study,' and the page revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-26T07:35:13.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    Administrative funding status notice was removed from the page. The rest of the study details, eligibility criteria, and intervention descriptions remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-19T08:23:56.000Z thumbnail image
  7. Check
    102 days ago
    Change Detected
    Summary
    The new screenshot shows minor formatting and wording adjustments across the page; core trial details, arms, outcomes, and listed locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T05:26:29.000Z thumbnail image

Stay in the know with updates to INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.